(Senior) Investment Analyst (m/f/d) - Full-time - Hybrid in Berlin, Munich or Luxembourg

Apollo Ventures; Berlin; Hybrid; EUR 60.000 - 90.000; Vollzeit

Zusammenfassung

A progressive venture builder based in Berlin seeks a qualified candidate to evaluate biotech opportunities and drive due diligence processes. Applicants should have advanced life sciences training and 1-3 years in venture capital or biotech. The role requires excellent data interpretation skills and clear communication in English. This position offers exposure to cutting-edge innovations and a flexible work environment.

Leistungen

Exposure to cutting-edge biotech innovations

Professional growth opportunities

Flexible work environment

Inclusive culture

Qualifikationen

• 1–3 years in venture capital, consulting, or biotech is a must.
• Solid understanding of drug development (discovery → preclinical → clinical).
• Willing to travel ~10%.

Aufgaben

• Evaluate cutting-edge science and biotech opportunities developing therapeutics.
• Drive due diligence, market landscaping, and portfolio support.
• Attend industry conferences to build deal flow.

Kenntnisse

Excellent preclinical data interpretation

Detail-oriented with big-picture judgment

Collaborative team player

Clear communicator in English

Self-starter and ownership mindset

Ausbildung

Advanced life sciences training (PhD / MD)

Jobbeschreibung

Apollo Health Ventures is a venture builder and early-stage investor backing innovative biotech companies developing therapies with meaningful patient impact, especially in aging biology and healthy lifespan. Our portfolio includes biotech companies such as Aeovian Pharmaceuticals, Haya Therapeutics, Therini Bio, and we have built companies such as Refoxy Pharma and Booster Therapeutics.

What you’ll do:

Evaluate cutting-edge science and early-stage biotech opportunities developing therapeutics.

Partner closely with our deal team, entrepreneurs, scientists, pharma, and co-investors.

Drive due diligence, market landscaping, portfolio support, and internal investment processes.

Help build transformative companies addressing high-unmet-need indications and healthy aging.

Keep abreast of industry trends, emerging technologies, and regulatory developments in life sciences.

Attend industry conferences, networking events, and scientific forums to build deal flow and maintain market intelligence.

This is a unique opportunity to sit at the intersection of science, entrepreneurship, and venture capital, and to work with a tight-knit team of experienced investors and company builders.

What we’re looking for:

• Advanced life sciences training (PhD / MD) or related field.

• Excellent preclinical data interpretation; detail-oriented with big-picture judgment also outside previous domain expertise.

• Solid understanding of drug development (discovery → preclinical → clinical).

• Clear, concise communicator in English (written and spoken).

• Collaborative team player comfortable with hybrid work in a partly remote team; willing to travel ~10%.

• High motivation, self-starter and ownership mindset.

• 1–3 years in venture capital, consulting, or biotech is a must.

What we offer:

• Exposure to cutting-edge biotech innovations and the venture capital investment process.

• Opportunity to work with a highly experienced, multidisciplinary team with deep industry networks.

• Professional growth opportunities and mentorship in venture investing.

• Flexible work environment and inclusive culture.

Interested in this position? Please apply via the link before October 15th 2025!